← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2010Last known activity
Mar 17, 2021
Timeline
No events for the selected filters.
Drugs by trial phase (3 distinct, 3 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (1 own, 0 via acquisition)
Indications
Studied for
Recent trials (10)
- NCT04788797Reponsible party - principal investigatorPhase 4Mar 17, 2021
- NCT04788797Lead sponsorPhase 4Mar 17, 2021
- NCT04788797Study chairPhase 4Mar 17, 2021
- NCT03271138Study directorPhase 2Jul 21, 2017
- NCT03271138Overall official - principal investigatorPhase 2Jul 21, 2017
- NCT03271138CollaboratorPhase 2Jul 21, 2017
- NCT01257620Overall official - principal investigatorN/ADec 1, 2010
- NCT01257620Reponsible party - principal investigatorN/ADec 1, 2010
- NCT01257620Lead sponsorN/ADec 1, 2010
- NCT01257620Study directorN/ADec 1, 2010
Details
- Last known activity
- Mar 17, 2021